ReportLinker
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares. - Market presence across multiple geographies - Strong/Active/Niche/Trivial.
New York, June 07, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Laboratory Information Systems (LIS) Industry" - https://www.reportlinker.com/p05957217/?utm_source=GNW - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass Research Platform - Complimentary updates for one year - Global Laboratory Information Systems (LIS) Market to Reach US$2.4 Billion by the Year 2026
- LIS is advanced software that stores and manages data in laboratories, and is used for sending test orders, recording laboratory test results, sorting data in databases. These platforms are widely used by clinics, hospitals and diagnostic laboratories to maintain data related to tests and medical history of patients, track data quality and send laboratory test orders. The demand for LIS is driven by their ability to enhance productivity, allow precise and accurate diagnosis, reduce diagnostic errors and improve patient satisfaction. The global market is poised to register significant growth in the future due to various factors such as rising incidence of chronic diseases, the huge volume of test data obtained from clinical testing, the need for enhanced lab automation and efficiency. The global market for these systems is also propelled by increasing adoption of digital solutions to store, retrieve and maintain data in real-time. These systems are offered by sophisticated analytic tools to deal with healthcare issues and improve overall productivity. The market is gaining from the need to reduce diagnostic errors, use of LIS to boost laboratory workflow efficiency, and incorporation of these systems with EHR systems. However, factors such as high maintenance cost, shortage of skilled professionals, and need for specialized laboratories remain key challenges for the market. On the other hand, huge investments by governments in LIS, increasing need for customized systems with data security functions and availability of advanced platforms are expected to present new growth avenues for the market. Rising adoption of laboratory automation and advances in R&D, particularly in biotechnology and pharmaceutical industries, are slated to push the market growth.
- Amid the COVID-19 crisis, the global market for Laboratory Information Systems (LIS) estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$2.4 Billion by 2026, growing at a CAGR of 9.2% over the analysis period. Standalone, one of the segments analyzed in the report, is projected to grow at a 6.6% CAGR to reach US$1.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Integrated segment is readjusted to a revised 12.2% CAGR for the next 7-year period. This segment currently accounts for a 41.9% share of the global Laboratory Information Systems (LIS) market. Based on product, standalone LIS segment is poised to hold a major share of the market during the analysis period, owing to key factors such as user-friendly nature, enhanced data security, affordability, and ability to work offline. As standalone LIS are not part of a software package, their ability to work offline augments its implementation. Technological innovations is also expected to further boost demand for standalone LIS. Integrated LIS is projected to witness faster growth during the analysis period. Against a backdrop of rising adoption of EMR, healthcare institutions are striving to achieve interoperability and standardization. This in turn spurred the shift from best-of-breed or standalone LIS to deployment of enterprise-wide integrated LIS. Integrated LIS lower dependencies on interfaces, vendor contracts, and total cost of ownership. The U.S. Market is Estimated at $825.5 Million in 2022, While China is Forecast to Reach $148.5 Million by 2026
- The Laboratory Information Systems (LIS) market in the U.S. is estimated at US$825.5 Million in the year 2022. The country currently accounts for a 52.9% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$148.5 Million in the year 2026 trailing a CAGR of 12.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR while Rest of European market (as defined in the study) will reach US$166.8 Million by the close of the analysis period. The US is at the forefront of adoption of LIS systems and dominates the global market, owing to favorable reimbursement policies in the country, for pathology procedures. The region is exhibiting strong gains on account of technological advancements and expansion of the healthcare sector, encompassing clinical research laboratories and diagnostic centers. Europe is another lucrative market for LIS. Developed countries like Germany for instance, are increasingly embracing automation in healthcare for reducing need for workforce. Healthcare providers in such markets are eagerly focusing on deploying automation like LIS for providing quality care to patients. The LIS market in Asia-Pacific, mainly China, is projected to post the fastest growth rate in the coming years due to extensive penetration of these systems in the region on account of surge in personalized medicine demand in the country and also rapid propagation of cloud LIS. Select Competitors (Total 254 Featured) Cerner Corporation Cirdan Comp Pro Med, Inc. CompuGroup Medical AG Margy Tech Pvt Ltd. McKesson Corporation Meditech Orchard Software Corporation Soft Computer Consultants Inc. Sunquest Information Systems, Inc. XIFIN Inc.
Read the full report: https://www.reportlinker.com/p05957217/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW Impact of Covid-19 and a Looming Global Recession The Never-Ending ?Race? Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond? Omicron Variant Brings Back Memories & Fears of the Worst Part of the 2020 Pandemic EXHIBIT 1: Time is of Essence! What We Know So Far - ?Vaccine Efficiency Against New Strains? With New Strains Emerging at an Alarming Rate, Focus Shifts to Booster Doses & Vaccine Tweaking. But How Practical Is It to Implement Them? EXHIBIT 2: With Vaccinated Population Showing Signs of Declining Clinical Protection, Booster Doses Are Emerging Into a Necessity to Restore Vaccine Effectiveness: Number of Booster Doses Administered Per 100 People by Country as of December 2021 With IMF Making an Upward Revision of Global GDP for 2022, Companies Are Bullish About a Continuing Economic Comeback Despite a Prolonging Pandemic EXHIBIT 3: A Strong Yet Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections: (Real GDP, Annual % Change) for 2020 through 2022 Overwhelming COVID-19 Testing Volumes Elevate Demand for Laboratory Information Systems EXHIBIT 4: Laboratory Information Systems (LIS) - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for 254 Players Worldwide in 2022 (E) A Prelude to Laboratory Information Systems (LIS) Functions of an Effective LIS Global Laboratory Information Systems Market to Witness Rapid Growth Standalone LIS Holds Major Share Services Segment Dominates the LIS Market, Software to Witness Higher Growth during the Forecast Period On-Premise LIS Holds Major Share Due to Customization Benefits Cloud-based LIS Model to Grow in Prominence due to Many Benefits Offered over Traditional, On-Premise Models US Holds Clear Edge over Other Regions, Asia-Pacific to Exhibit Fastest Growth RECENT MARKET ACTIVITY
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS Introduction of Advanced Technologies Fuel Demand for Laboratory Information Systems Digitization of Healthcare Drives Integration of LIS Accelerating Pace of Digital Pathology Increase Adoption Increasing Concerns Pertaining to Data Integrity Fuel Demand for Laboratory Information Systems Introduction of Stringent Data Protection Guidelines Propel Demand for Laboratory Information System Software Use of Easy to Integrate Laboratory Information Systems Gain Momentum Artificial Intelligence Gains Prominence EXHIBIT 5: AI Spending in Healthcare & Life sciences in US$ Million for Years 2020 & 2025 Burgeoning Population and Rising Incidence of Chronic Diseases: A Key Market Driver for LIS EXHIBIT 6: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others EXHIBIT 7: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 EXHIBIT 8: Breakdown of Total Number of Cancer Cases by Cancer Site: 2020 EXHIBIT 9: Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045 Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for Laboratory Information System/LIS market EXHIBIT 10: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030 Growing Adoption of Laboratory Automation Drives the Need for LIS Rise of Laboratory 4.0 to Spur the Adoption of LIS EXHIBIT 11: World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026 Laboratory Information Systems Gain Traction amidst Growing Need to Enhance Workflow Efficiencies and Reduce Costs Rise in Molecular Testing Volumes to Elevate Demand EXHIBIT 12: Global Genetic Testing Market in US$ Million: 2015, 2020, & 2025 Improving Healthcare Expenditure to Turbo Charge Future Growth of the Market EXHIBIT 13: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 EXHIBIT 14: Elderly Healthcare Expenditure as a % of GDP Need to Improve Diagnostics Accuracy Increasing Popularity of Enterprise LIS Rise in Consolidation of Healthcare Providers Creates Need for Robust and Comprehensive LIS Growing Emphasis on Personalized Medicine to Support Growth EXHIBIT 15: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025 Rise in Investment in R&D Activity to Spur Growth Shortage of Trained Professionals Hinders Adoption Rate
4. GLOBAL MARKET PERSPECTIVE Table 1: World Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Laboratory Information Systems (LIS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Laboratory Information Systems (LIS) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Standalone by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for Integrated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Integrated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Integrated by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 22: World Recent Past, Current & Future Analysis for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Hospital Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 25: World Recent Past, Current & Future Analysis for Independent Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 26: World Historic Review for Independent Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Independent Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
Table 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES Laboratory Information Systems (LIS) Market Presence - Strong/ Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) Market Analytics Table 31: USA Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Product - Standalone and Integrated - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 32: USA Historic Review for Laboratory Information Systems (LIS) by Product - Standalone and Integrated Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 33: USA 15-Year Perspective for Laboratory Information Systems (LIS) by Product - Percentage Breakdown of Value Revenues for Standalone and Integrated for the Years 2012, 2021 & 2027
Table 34: USA Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 35: USA Historic Review for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 36: USA 15-Year Perspective for Laboratory Information Systems (LIS) by Deployment - Percentage Breakdown of Value Revenues for On-Premise and Cloud for the Years 2012, 2021 & 2027
Table 37: USA Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Component - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 38: USA Historic Review for Laboratory Information Systems (LIS) by Component - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 39: USA 15-Year Perspective for Laboratory Information Systems (LIS) by Component - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
Table 40: USA Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by End-Use - Hospital Laboratories, Independent Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 41: USA Historic Review for Laboratory Information Systems (LIS) by End-Use - Hospital Laboratories, Independent Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 42: USA 15-Year Perspective for Laboratory Information Systems (LIS) by End-Use - Percentage Breakdown of Value Revenues for Hospital Laboratories, Independent Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
CANADA Table 43: Canada Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Product - Standalone and Integrated - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 44: Canada Historic Review for Laboratory Information Systems (LIS) by Product - Standalone and Integrated Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 45: Canada 15-Year Perspective for Laboratory Information Systems (LIS) by Product - Percentage Breakdown of Value Revenues for Standalone and Integrated for the Years 2012, 2021 & 2027
Table 46: Canada Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 47: Canada Historic Review for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 48: Canada 15-Year Perspective for Laboratory Information Systems (LIS) by Deployment - Percentage Breakdown of Value Revenues for On-Premise and Cloud for the Years 2012, 2021 & 2027
Table 49: Canada Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Component - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 50: Canada Historic Review for Laboratory Information Systems (LIS) by Component - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 51: Canada 15-Year Perspective for Laboratory Information Systems (LIS) by Component - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
Table 52: Canada Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by End-Use - Hospital Laboratories, Independent Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 53: Canada Historic Review for Laboratory Information Systems (LIS) by End-Use - Hospital Laboratories, Independent Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 54: Canada 15-Year Perspective for Laboratory Information Systems (LIS) by End-Use - Percentage Breakdown of Value Revenues for Hospital Laboratories, Independent Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN Table 55: Japan Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Product - Standalone and Integrated - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 56: Japan Historic Review for Laboratory Information Systems (LIS) by Product - Standalone and Integrated Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 57: Japan 15-Year Perspective for Laboratory Information Systems (LIS) by Product - Percentage Breakdown of Value Revenues for Standalone and Integrated for the Years 2012, 2021 & 2027
Table 58: Japan Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 59: Japan Historic Review for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 60: Japan 15-Year Perspective for Laboratory Information Systems (LIS) by Deployment - Percentage Breakdown of Value Revenues for On-Premise and Cloud for the Years 2012, 2021 & 2027
Table 61: Japan Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Component - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 62: Japan Historic Review for Laboratory Information Systems (LIS) by Component - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 63: Japan 15-Year Perspective for Laboratory Information Systems (LIS) by Component - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
Table 64: Japan Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by End-Use - Hospital Laboratories, Independent Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 65: Japan Historic Review for Laboratory Information Systems (LIS) by End-Use - Hospital Laboratories, Independent Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 66: Japan 15-Year Perspective for Laboratory Information Systems (LIS) by End-Use - Percentage Breakdown of Value Revenues for Hospital Laboratories, Independent Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
CHINA Table 67: China Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Product - Standalone and Integrated - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 68: China Historic Review for Laboratory Information Systems (LIS) by Product - Standalone and Integrated Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 69: China 15-Year Perspective for Laboratory Information Systems (LIS) by Product - Percentage Breakdown of Value Revenues for Standalone and Integrated for the Years 2012, 2021 & 2027
Table 70: China Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 71: China Historic Review for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 72: China 15-Year Perspective for Laboratory Information Systems (LIS) by Deployment - Percentage Breakdown of Value Revenues for On-Premise and Cloud for the Years 2012, 2021 & 2027
Table 73: China Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Component - Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 74: China Historic Review for Laboratory Information Systems (LIS) by Component - Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 75: China 15-Year Perspective for Laboratory Information Systems (LIS) by Component - Percentage Breakdown of Value Revenues for Services and Software for the Years 2012, 2021 & 2027
Table 76: China Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by End-Use - Hospital Laboratories, Independent Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 77: China Historic Review for Laboratory Information Systems (LIS) by End-Use - Hospital Laboratories, Independent Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 78: China 15-Year Perspective for Laboratory Information Systems (LIS) by End-Use - Percentage Breakdown of Value Revenues for Hospital Laboratories, Independent Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE Laboratory Information Systems (LIS) Market Presence - Strong/ Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) Market Analytics Table 79: Europe Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 80: Europe Historic Review for Laboratory Information Systems (LIS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 81: Europe 15-Year Perspective for Laboratory Information Systems (LIS) by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Table 82: Europe Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Product - Standalone and Integrated - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 83: Europe Historic Review for Laboratory Information Systems (LIS) by Product - Standalone and Integrated Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 84: Europe 15-Year Perspective for Laboratory Information Systems (LIS) by Product - Percentage Breakdown of Value Revenues for Standalone and Integrated for the Years 2012, 2021 & 2027
Table 85: Europe Recent Past, Current & Future Analysis for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 86: Europe Historic Review for Laboratory Information Systems (LIS) by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 87: Europe 15-Year Perspective for Laboratory Information Systems (LIS) by Deployment - Percentage Breakdown of Value Revenues for On-Premise and Cloud for the Years 2012, 2021 & 2027
The rest is here:
Global Laboratory Information Systems (LIS) Market to Reach US$2.4 Billion by the Year 2026 - Yahoo Finance
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022
- AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions... - June 8th, 2022
- Time to Rethink Metformin as First-Line Therapy? Perspective from ADA 2022 - Endocrinology Network - June 8th, 2022
- PreludeDx Presents New DCISionRT Data on the Effectiveness of Endocrine Therapy in DCIS Patients at the ASCO 2022 Annual Meeting - 69News WFMZ-TV - June 8th, 2022
- BITS Pilani Hyderabad to conduct 'Precision Medicine 2022' event tomorrow - United News of India - June 8th, 2022
- Medical Nutrition Market Promising Growth Opportunities and Forecast 2027 - Digital Journal - June 8th, 2022
- 57% of Organizations in India are at the Startup Stage of Genomics High-Performance Computing Infrastructure - APN News - June 8th, 2022
- Cellworks Singula TRI Provides Personalized OS and PFS Predictions for 18 NCCN Guideline GBM Therapies - StreetInsider.com - June 8th, 2022
- Inspiration for the laboratory of tomorrow - Chemie.de - June 8th, 2022
- Global Nanomaterials in Personalized Medicine Market (Impact Of COVID-19) Growth, Overview With Detailed Analysis 2022-2028 Queen Anne and Mangolia... - May 8th, 2022
- The global biomarkers market is expected to grow at a CAGR of 11.44%. - Yahoo Finance - May 8th, 2022
- Bioinformatics Market Size, Share, And Trends Analysis Report, By Application (Drug Development, Protein Function Analysis, Gene Therapy, Molecular... - May 8th, 2022
- Link between EBV and MS may give clues to the cause of long COVID - The Arizona Republic - May 8th, 2022
- Improving Cell Cultures with Thermoresponsive Coatings - Genetic Engineering & Biotechnology News - May 8th, 2022
- Reevaluating, Reimagining, And Reinventing Healthcare: Innovation In A Post-Pandemic World - Forbes - May 8th, 2022
- Study of Cancer Genetics to Help with Targeted Treatment - VOA Learning English - May 8th, 2022
- Increased demand for Molecular diagnostics after the COVID-19 outbreak - The Financial Express - May 8th, 2022
- CIOs' 5-year plans for precision medicine and emerging technologies - Healthcare IT News - January 30th, 2022
- SeqOne Genomics Closes 20M Series a to Accelerate the Deployment of Its Genomic Medicine Platform - Business Wire - January 30th, 2022
- Study: In IBS patients, cognitive behavioral therapy modulates the brain-gut microbiome and helps relieve symptoms - UB News Center - January 30th, 2022
- (New Report) Digital Genome Market In 2022 : The Increasing use in Diagnostics, Agriculture & Animal Research, Personalized Medicine, Drug... - January 30th, 2022
- Silencing a faulty gene may uncover clues to rare forms of ALS - National Institutes of Health - January 30th, 2022
- Plants, Bioprinting and Orbital Plumbing Fill Crew's Thursday Schedule - NASA - January 30th, 2022
- ClarityX DNA: The Key to Tackling Seasonal Affective Disorder - PR Web - January 30th, 2022
- Global High Performance Computing Market 2022-2027: AI, IoT, and 5G will be Major Drivers for HPC Growth as they Facilitate the Need to Process Vast... - January 30th, 2022